03-15-2019 10:08 AM CET - Business, Economy, Finances, Banking & Insurance

Breast Cancer Liquid Biopsy Market: Global Product Intelligence, Industry Analysis, Size, Share, Growth, Trends and Forecast - 2024

Press release from: Infinium Global Research
PR Agency: Infinium Global Research
Breast Cancer Liquid Biopsy Market
Breast Cancer Liquid Biopsy Market
A complete view of Breast Cancer Liquid Biopsy is provided based on definitions, product classification, applications, major players driving the global Breast Cancer Liquid Biopsy Market share and revenue. The information in the form of graphs, pie charts will lead to an easy analysis of an industry. The market share of top leading players, their plans and business policies, growth factors will help other players in gaining useful business tactics.

The forecast Breast Cancer Liquid Biopsy market information is based on the present market situation, growth opportunities, development factors, and opinion of the industry experts. An in-depth analysis of the company profiles, Breast Cancer Liquid Biopsy Market on the global and regional level and applications is conducted. The analysis of downstream buyers, sales channel, raw materials, and industry verticals is offered in this report.

Download Exclusive Sample Copy of Report: www.infiniumglobalresearch.com/reports/sample-request/3386

Breast Cancer Liquid Biopsy Market: Industry Insights

The liquid bioscopy in breast cancer is simple processes that enable the Traces of cancer's DNA through a simple blood sample. It helps to collect a range of information that further helps to describe the most suitable treatment for the patients. This is a non-invasive alternative to surgical biopsies. Liquid bioscopy test detects epidermal growth factor receptor (EGFR) gene mutations that assist doctors to choose the right treatment at the right time.

Breast Cancer Liquid Biopsy Market: Drivers and Restraints

The rapidly growing demand for non-invasive cancer treatment and the growing prevalence of cancer are the major factors that drive the growth of the breast cancer market. The Prevalence of breast cancer across the world is 2,093,876 in 2018. Breath cancer is the second largest cause of death worldwide. Thus, this is anticipated to boost the growth of breast cancer liquid biopsy market. Furthermore, the demand for non-invasive cancer treatments coupled with its advantages over the traditional treatments is favoring the market growth.

Breast Cancer Liquid Biopsy Market: Segmentation

The global breasts cancer liquid biopsy market is segmented as a biomarker, and end-user. In terms of the biomarker, the breast cancer liquid biopsy market is categorized as extracellular vesicles (EVs), cell-free DNA (cfDNA), circulating tumor cells (CTCs), and other circulating biomarkers. Cancer biomarkers are biological molecules found in blood, other body fluids, or tissues that are secreted by the cancerous tumor. The extracellular vesicles (EVs) offers drug resistance, invasiveness and stemness across cancer cells, increased proliferation rate. It includes cancer-associated molecules such as glycoproteins, various non-coding RNAs and DNA fragments and mRNAs. Additionally, several countries have a strong government focus on healthcare costs and are implementing cost-effective health technology assessments that contribute to the growth of the extracellular vesicles (EVs) biomarkers in this market. By end users, the market classified into hospitals and physician laboratories, reference laboratories, and others.

More Insights on this report, Speak to Our Analyst: www.infiniumglobalresearch.com/reports/enquiry/3386

Breast Cancer Liquid Biopsy Market: Regional Insights

Geographically, North America holds the maximum market share in the breasts cancer liquid biopsy market followed by Europe. High prevalence of breast cancer is the primary factor that drives the growth of North America breast cancer liquid biopsy market. According to the Breastcancer.org, in the U.S., breast cancer death rates are higher than those for any other cancer, besides lung cancer. In addition, the advancements in the cancer treatment, and developed healthcare infrastructure are contributing to breast cancer liquid biopsy market in this region. Moreover, Asia Pacific is the fastest growing region in the breast cancer liquid biopsy market.

Breast Cancer Liquid Biopsy Market: Competitive Analysis

The key companies in the global breast cancer liquid biopsy market include Isogen Life Science, GUARDANT HEALTH, INC, Biodesix, Inc., FLUXION BIOSCIENCES, Thermo Fisher Scientific Inc., Genomic Health, Cynvenio Biosystems, Inc., Illumina, Inc., Menarini Silicon Biosystems, and Myriad Genetics, Inc. among others. Major players in this market are focusing on the new product launch to enhance their product portfolio. For instance, Biocept, Inc. one of the leading commercial provider of liquid biopsy tests for ESR1 Biomarker Detection. This test is designed to offer physicians with clinically actionable information to advance the outcomes of patients diagnosed with cancer.

To know more about the Breast Cancer Liquid Biopsy Market Visit the link- www.infiniumglobalresearch.com/healthcare-medical-devices...

Reasons to Buy this Report:

• Comprehensive analysis of global as well as regional markets of the Breast Cancer Liquid Biopsy.
• Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2024.
• Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
• Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

About Infinium Global Research

Infinium Global Research and Consulting Solutions is started with a single motto of being a business partner of the first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you. With our strategic research approaches and deep dive in the market segments, we try to find out new opportunities that our clients can encash with their existing resources. Our experts with over 100 years of cumulative experience in research offer the best in the industry services to our clients to ensure that they achieve their business goals.

Contact Us:

Infinium Global Research
Office No. 04, 06, Ganadhish Empire,
Rahatani Corner, Pune, MH 411027
Email: info@infiniumglobalresearch.com
Website: www.infiniumglobalresearch.com

This release was published on openPR.
News-ID: 1656431 • Views: 175
More releasesMore releases

You can edit or delete your press release here: